<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Jpn J Cancer Res</journal-id><journal-id journal-id-type="iso-abbrev">Jpn. J. Cancer Res</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1349-7006a</journal-id><journal-id journal-id-type="publisher-id">CAS</journal-id><journal-title-group><journal-title>Japanese Journal of Cancer Research : Gann</journal-title></journal-title-group><issn pub-type="ppub">0910-5050</issn><issn pub-type="epub">1876-4673</issn><publisher><publisher-name>Blackwell Publishing Ltd</publisher-name><publisher-loc>Oxford, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">8514613</article-id><article-id pub-id-type="pmc">5919309</article-id><article-id pub-id-type="doi">10.1111/j.1349-7006.1993.tb00158.x</article-id><article-id pub-id-type="publisher-id">CAE455</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Effects of Chemoendocrine Therapy on the Coagulation&#x02010;Fibrinolytic Systems in Patients with Advanced Breast Cancer</article-title></title-group><contrib-group><contrib id="cr1" contrib-type="author"><collab collab-type="authors">Japan Advanced Breast Cancer Study Group</collab></contrib><contrib id="cr2" contrib-type="author"><collab collab-type="authors">Japan Clinical Oncology Group</collab></contrib></contrib-group><author-notes><corresp id="correspondenceTo">All correspondence should be addressed to: Takashi Fukutomi, M.D., Department of Surgery, National Cancer Center Hospital, 1&#x02013;1 Tsukiji 5&#x02010;chome, Chuo&#x02010;ku, Tokyo 104.</corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>1993</year></pub-date><volume>84</volume><issue>4</issue><issue-id pub-id-type="doi">10.1111/cas.1993.84.issue-4</issue-id><fpage>455</fpage><lpage>461</lpage><history>
(Received November 24, 1992/Accepted January 26, 1993)</history><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:CAS-84-455.pdf"/><abstract><p>In order to predict a hypercoagulable state in patients with advanced breast cancer receiving medical treatment, the effects of Chemoendocrine therapy on the coagulation&#x02010;flbrinolytic systems were investigated prospectively. The patients were randomly divided into two groups. The ACT group had 38 patients, who received 20 mg/m<sup>2</sup> adriamycin (ADM) i.v. on days 1 and 8, 100 mg cyclophosphamide (CPA) p.o. on days 1&#x02013;14, and 20 mg tamoxifen (TAM) p.o. daily. The ACM group had 44 patients, who received 20 mg/m<sup>2</sup> ADM i.v. on days 1 and 8, 100 mg CPA p.o. on days 1&#x02013;14 and 1200 mg medroxyprogesterone acetate (MPA) p.o. daily. The treatment was repeated every 28 days until there was evidence of progressive disease or until the full ADM dose (550 mg/m<sup>2</sup>) had been given. The following 9 hematologic parameters were measured every 4 weeks: alpha 2&#x02010;plasmin inhibitor plasmin complex (PIC), anti&#x02010;thrombin&#x02010;III (AT&#x02010;III), D&#x02010;dimer (Dd), fibrinogen (Fg), plasminogen (Pg), protein C (PC), thrombin&#x02010;antithrombin&#x02010;III complex (TAT&#x02010;III), tissue plasminogen activator (t&#x02010;PA), and factor &#x000d7; (FX). Compared to the ACT group, patients in the ACM group showed significantly higher values of AT&#x02010;III and PC, which exceeded the normal ranges. The levels of Pg, t&#x02010;PA and FX were significantly higher in the ACM group than in the ACT group, but were still within the normal ranges. The levels of TAT&#x02010;III, Dd and PIC decreased in the ACT group and were unchanged in the ACM group after the start of treatment. Fg remained unchanged in both groups after the start of treatment. One patient in the ACM group had thrombophlebitis of the lower extremities with high levels of TAT&#x02010;III, Dd and PIC and a decrease of Fg, but her condition returned to normal after reduction of the MPA dose. Although these data are not directly indicative of a hypercoagulable state in patients receiving Chemoendocrine therapy, changes in AT&#x02010;III, TAT&#x02010;III, Dd and PIC should be monitored carefully when this type of treatment is given.</p></abstract><kwd-group><kwd id="k1">Tamoxifen</kwd><kwd id="k2">Medroxyprogesterone acetate</kwd><kwd id="k3">Coagulation</kwd><kwd id="k4">Fibrinolysis</kwd><kwd id="k5">Breast cancer</kwd></kwd-group><counts><ref-count count="15"/><page-count count="7"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 1993</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.6.9 mode:remove_FC converted:04.11.2015</meta-value></custom-meta></custom-meta-group></article-meta></front><back><ref-list id="ss1"><title>REFERENCES</title><ref id="b1"><label>1</label><mixed-citation publication-type="journal" id="cit1">
)
<string-name><surname>Lipton</surname>
,
<given-names>A.</given-names></string-name>
,
<string-name><surname>Harvey</surname>
,
<given-names>H.</given-names></string-name>
and
<string-name><surname>Hamilton</surname>
,
<given-names>R. W.</given-names></string-name><article-title>Venous thrombosis as a side effect of tamoxifen treatment</article-title>
.
<source>Cancer Treat. Rep.</source>
,
<volume>68</volume>
,
<fpage>887</fpage>
&#x02013;
<lpage>889</lpage>
(
<year>1984</year>
).
<pub-id pub-id-type="pmid">6733701</pub-id></mixed-citation></ref><ref id="b2"><label>2</label><mixed-citation publication-type="journal" id="cit2">
)
<string-name><surname>Hendrik</surname>
,
<given-names>A</given-names></string-name>
,
and
<string-name><surname>Subramanian</surname>
,
<given-names>V. P.</given-names></string-name><article-title>Tamoxifen and thromboembolism</article-title>
.
<source>J. Am. Med. Assoc.</source>
,
<volume>243</volume>
,
<fpage>514</fpage>
&#x02013;
<lpage>515</lpage>
(
<year>1980</year>
).
</mixed-citation></ref><ref id="b3"><label>3</label><mixed-citation publication-type="journal" id="cit3">
)
<string-name><surname>Yamamoto</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Noguchi</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Miyauchi</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Inaji</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Imaoka</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Koyama</surname>
,
<given-names>H.</given-names></string-name>
and
<string-name><surname>Iwanaga</surname>
,
<given-names>T.</given-names></string-name><article-title>Changes in hematologic parameters during treatment with medroxy&#x02010;progesterone acetate for breast cancer</article-title>
.
<source>Jpn. J. Cancer Res.</source>
,
<volume>82</volume>
,
<fpage>420</fpage>
&#x02013;
<lpage>425</lpage>
(
<year>1991</year>
).
<pub-id pub-id-type="pmid">1828463</pub-id></mixed-citation></ref><ref id="b4"><label>4</label><mixed-citation publication-type="journal" id="cit4">
)
<string-name><surname>Saphner</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Tormey</surname>
,
<given-names>D. C.</given-names></string-name>
and
<string-name><surname>Gray</surname>
,
<given-names>R.</given-names></string-name><article-title>Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer</article-title>
.
<source>J. Clin. Oncol.</source>
,
<volume>9</volume>
,
<fpage>286</fpage>
&#x02013;
<lpage>294</lpage>
(
<year>1991</year>
).
<pub-id pub-id-type="pmid">1988575</pub-id></mixed-citation></ref><ref id="b5"><label>5</label><mixed-citation publication-type="journal" id="cit5">
)
<string-name><surname>Elms</surname>
,
<given-names>M. J.</given-names></string-name>
,
<string-name><surname>Bunce</surname>
,
<given-names>I. H.</given-names></string-name>
,
<string-name><surname>Bundensen</surname>
,
<given-names>P. G.</given-names></string-name>
,
<string-name><surname>Rylatt</surname>
,
<given-names>D. B.</given-names></string-name>
,
<string-name><surname>Webber</surname>
,
<given-names>A. J.</given-names></string-name>
,
<string-name><surname>Masci</surname>
,
<given-names>P. P.</given-names></string-name>
and
<string-name><surname>Whitaker</surname>
,
<given-names>A. N.</given-names></string-name><article-title>Measurement of crosslinked fibrin degradation products &#x02014; an immunoassay using monoclonal antibodies</article-title>
.
<source>Thromb. Haemostasis</source>
,
<volume>50</volume>
,
<fpage>591</fpage>
&#x02013;
<lpage>594</lpage>
(
<year>1983</year>
).
<pub-id pub-id-type="pmid">6356456</pub-id></mixed-citation></ref><ref id="b6"><label>6</label><mixed-citation publication-type="journal" id="cit6">
)
<string-name><surname>Shimamoto</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Yoshimura</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Kimura</surname>
,
<given-names>N.</given-names></string-name>
,
<string-name><surname>Kita</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Hoshino</surname>
,
<given-names>N.</given-names></string-name>
,
<string-name><surname>Motoi</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Suehisa</surname>
,
<given-names>E.</given-names></string-name>
,
<string-name><surname>Nishimura</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Hayashi</surname>
,
<given-names>C.</given-names></string-name>
and
<string-name><surname>Miyai</surname>
,
<given-names>K.</given-names></string-name><article-title>Protein C in human plasma determined by homogeneous enzyme immunoassay with use of a centrifugal analyzer</article-title>
.
<source>Clin. Chem.</source>
,
<volume>34</volume>
,
<fpage>1834</fpage>
&#x02013;
<lpage>1838</lpage>
(
<year>1988</year>
).
<pub-id pub-id-type="pmid">3046778</pub-id></mixed-citation></ref><ref id="b7"><label>7</label><mixed-citation publication-type="journal" id="cit7">
)
<string-name><surname>Pelzer</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Schwarz</surname>
,
<given-names>A.</given-names></string-name>
and
<string-name><surname>Heimburger</surname>
,
<given-names>N.</given-names></string-name><article-title>Determination of human thrombin&#x02010;antithrombin complex in plasma with an enzyme&#x02010;linked immunosorbent assay</article-title>
.
<source>Thromb. Haemostasis</source>
,
<volume>59</volume>
,
<fpage>101</fpage>
&#x02013;
<lpage>106</lpage>
(
<year>1988</year>
).
<pub-id pub-id-type="pmid">3363526</pub-id></mixed-citation></ref><ref id="b8"><label>8</label><mixed-citation publication-type="journal" id="cit8">
)
<string-name><surname>Bergsdorf</surname>
,
<given-names>N.</given-names></string-name>
,
<string-name><surname>Nilsson</surname>
,
<given-names>T.</given-names></string-name>
and
<string-name><surname>Wallen</surname>
,
<given-names>P.</given-names></string-name><article-title>An enzyme&#x02010;linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease</article-title>
.
<source>Thromb. Haemostasis</source>
,
<volume>50</volume>
,
<fpage>740</fpage>
&#x02013;
<lpage>744</lpage>
(
<year>1983</year>
).
<pub-id pub-id-type="pmid">6359572</pub-id></mixed-citation></ref><ref id="b9"><label>9</label><mixed-citation publication-type="journal" id="cit9">
)
<string-name><surname>Dati</surname>
,
<given-names>F.</given-names></string-name>
,
<string-name><surname>Barthels</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Conard</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>Flueckiger</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>Girolami</surname>
,
<given-names>A.</given-names></string-name>
,
<string-name><surname>Haenseler</surname>
,
<given-names>E.</given-names></string-name>
,
<string-name><surname>Huber</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>Keller</surname>
,
<given-names>F.</given-names></string-name>
,
<string-name><surname>Kolde</surname>
,
<given-names>H. J.</given-names></string-name>
,
<string-name><surname>Mueller&#x02010;Berghaus</surname>
,
<given-names>G.</given-names></string-name>
,
<string-name><surname>Samama</surname>
,
<given-names>M.</given-names></string-name>
and
<string-name><surname>Thiel</surname>
,
<given-names>W.</given-names></string-name><article-title>Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time</article-title>
.
<source>Thromb, Haemostasis</source>
,
<volume>58</volume>
,
<fpage>856</fpage>
&#x02013;
<lpage>865</lpage>
(
<year>1987</year>
).
<pub-id pub-id-type="pmid">3433249</pub-id></mixed-citation></ref><ref id="b10"><label>10</label><mixed-citation publication-type="journal" id="cit10">
)
<string-name><surname>Fukutomi</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Nanasawa</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Yamamoto</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Adachi</surname>
,
<given-names>I.</given-names></string-name>
and
<string-name><surname>Watanabe</surname>
,
<given-names>T.</given-names></string-name><article-title>The induction of a hypercoagulable state by medroxyprogesterone acetate in breast cancer patients</article-title>
.
<source>Jpn. J. Surg.</source>
,
<volume>20</volume>
,
<fpage>665</fpage>
&#x02013;
<lpage>670</lpage>
(
<year>1990</year>
).
<pub-id pub-id-type="pmid">2150678</pub-id></mixed-citation></ref><ref id="b11"><label>11</label><mixed-citation publication-type="journal" id="cit11">
)
<string-name><surname>Scully</surname>
,
<given-names>M. F.</given-names></string-name>
and
<string-name><surname>Kakkar</surname>
,
<given-names>V. V.</given-names></string-name><article-title>Methods for semimicro or automated determination of thrombin, antithrombin, and heparin cofactor using the substrate, H&#x02010;D&#x02010;Phe&#x02010;Pip&#x02010;Arg&#x02010;p&#x02010;nitroanilide 2Hcl</article-title>
.
<source>Clin. Chim. Acta</source>
,
<volume>79</volume>
,
<fpage>595</fpage>
&#x02013;
<lpage>602</lpage>
(
<year>1977</year>
).
<pub-id pub-id-type="pmid">70286</pub-id></mixed-citation></ref><ref id="b12"><label>12</label><mixed-citation publication-type="journal" id="cit12">
)
<string-name><surname>Harpel</surname>
,
<given-names>P. C.</given-names></string-name><article-title>Alpha 2&#x02010;plasmin inhibitor and alpha 2&#x02010;macroglobulin&#x02010;plasmin complexes in plasma</article-title>
.
<source>J. Clin. Invest.</source>
,
<volume>68</volume>
,
<fpage>46</fpage>
&#x02013;
<lpage>55</lpage>
(
<year>1981</year>
).
<pub-id pub-id-type="pmid">6166634</pub-id></mixed-citation></ref><ref id="b13"><label>13</label><mixed-citation publication-type="journal" id="cit13">
)
<string-name><surname>Love</surname>
,
<given-names>R. R.</given-names></string-name>
,
<string-name><surname>Surawicz</surname>
,
<given-names>T. S.</given-names></string-name>
and
<string-name><surname>Williams</surname>
,
<given-names>E. C.</given-names></string-name><article-title>Antithrombin III level, fibrinogen level, and platelet count changes with adjuvant tamoxifen therapy</article-title>
.
<source>Arch. Intern. Med.</source>
,
<volume>152</volume>
,
<fpage>317</fpage>
&#x02013;
<lpage>320</lpage>
(
<year>1992</year>
).
<pub-id pub-id-type="pmid">1739360</pub-id></mixed-citation></ref><ref id="b14"><label>14</label><mixed-citation publication-type="journal" id="cit14">
)
<string-name><surname>Bounameaux</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Cirafici</surname>
,
<given-names>P.</given-names></string-name>
,
<string-name><surname>De Moerloose</surname>
,
<given-names>P.</given-names></string-name>
,
<string-name><surname>Schneider</surname>
,
<given-names>P. A.</given-names></string-name>
,
<string-name><surname>Slosman</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>Reber</surname>
,
<given-names>G.</given-names></string-name>
and
<string-name><surname>Unger</surname>
,
<given-names>P. F.</given-names></string-name><article-title>Measurement of D&#x02010;dimer in plasma as diagnostic aid in suspected pulmonary embolism</article-title>
.
<source>Lancet</source>
,
<volume>337</volume>
,
<fpage>196</fpage>
&#x02013;
<lpage>200</lpage>
(
<year>1991</year>
).
<pub-id pub-id-type="pmid">1670841</pub-id></mixed-citation></ref><ref id="b15"><label>15</label><mixed-citation publication-type="book" id="cit15">
)
<string-name><surname>Rosso</surname>
,
<given-names>R.</given-names></string-name>
,
<string-name><surname>Boccardo</surname>
,
<given-names>F.</given-names></string-name>
,
<string-name><surname>Canobbio</surname>
,
<given-names>L.</given-names></string-name>
,
<string-name><surname>Queirolo</surname>
,
<given-names>M. A.</given-names></string-name>
,
<string-name><surname>Zarcone</surname>
,
<given-names>D.</given-names></string-name>
and
<string-name><surname>Brema</surname>
,
<given-names>F.</given-names></string-name><chapter-title>Effects of high&#x02010;dose medroxyprogesterone acetate on blood&#x02010;clotting factors and platelet function</chapter-title>
.
In
&#x0201c;
<source>Proceedings of the International Symposium on Medroxyprogesterone Acetate</source>
,&#x0201d;
ed.
<person-group person-group-type="editor"><name><surname>Cavalli</surname><given-names>F.</given-names></name></person-group>
,
<person-group person-group-type="editor"><name><surname>McGuire</surname><given-names>W. L.</given-names></name></person-group>
,
<person-group person-group-type="editor"><name><surname>Pannuti</surname><given-names>F.</given-names></name></person-group>
,
<person-group person-group-type="editor"><name><surname>Pellegrini</surname><given-names>A.</given-names></name></person-group>
and
<person-group person-group-type="editor"><name><surname>Robustelli Delia Cuna</surname><given-names>G.</given-names></name></person-group>
,
pp.
<fpage>151</fpage>
&#x02013;
<lpage>157</lpage>
(
<year>1982</year>
).
<publisher-name>Excerpta Medica</publisher-name>
,
Amsterdam&#x02010;Oxford&#x02010;Princeton
.
</mixed-citation></ref></ref-list></back></article>